Key result
Ephrin-B2 alters Ang-1 and highly upregulates Ang-2 in a rat model of focal cerebral ischemia.
Ephrin-B2 modulates the expression of Ang-1 and Ang-2 during angiogenesis following transient focal cerebral ischemia in rats.
Answers are grounded in this paper and cite their sources.
Ephrin-B2 modulates post-ischemic angiogenesis in rats; hypothesis-generating and should not yet inform clinical stroke practice.
Ephrin-B2 has been shown to participate in angiogenesis, but the underlying mechanisms involved remain unclear. In this study, a rat model of focal cerebral ischemia was prepared by focal middle cerebral artery occlusion, followed by 24-hour reperfusion. Then, ephrin-B2 protein was administered intracerebroventricularly for 3 consecutive days via a micro-osmotic pump. Western blot assay and quantitative real-time reverse transcription PCR demonstrated the expression levels of angiopoietin-1 (Ang-1) mRNA and protein in the penumbra cortex of the ephrin-B2 treated group were decreased at day 4 after reperfusion, and increased at day 28, while the expression levels of angiopoietin-2 (Ang-2) were highly up-regulated at all time points tested. Double immunofluorescent staining indicated that Ang-1 and Ang-2 were both expressed in vascular endothelial cells positive for CD31. These findings indicate that ephrin-B2 influences the expressions of Ang-1 and Ang-2 during angiogenesis following transient focal cerebral ischemia.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2016) studied Focal cerebral ischemia/reperfusion. Ephrin-B2 protein was evaluated on Expression levels of angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) mRNA and protein in the penumbra cortex. Intracerebroventricular administration of ephrin-B2 decreased Ang-1 expression at day 4 and increased it at day 28, while highly up-regulating Ang-2 expression at all tested time points in a rat model of focal cerebral ischemia.
Synapse has enriched 10 related papers. Consider them for comparative context: